Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion

Summary

The purpose of this study is to determine whether continued administration of Drotrecogin Alfa (Activated) up to additional 72 hours - after the so far recommended 96 hour infusion period - results in a more rapid resolution of hypotension in severe septic patients.

Timeline

Start

2004-06

Primary completion

—

Completion

2007-05

Drugs

Indications